The Victorian government said it is supporting the next generation of workers in the mRNA vaccine and medicine field so that more life-saving therapies can be discovered and manufactured in the state.
An investment of $10 million will be made to operate the Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training, which will provide highly specialised training to workers across all aspects of the mRNA manufacturing life cycle.
Premier Daniel Andrews and industry and innovation minister Ben Carroll today met with the centre’s new Director Associate Professor Jennifer Short and future mRNA workers – who will provide Victoria’s sovereign mRNA manufacturing industry with the highly skilled workforce we need to produce the next generation of vaccines and medicines.
“Victoria is already a world leader in medical research and mRNA technology – this centre will make sure we can train the highly-skilled workers we need to deliver more lifesaving vaccines and medicines right here,” premier Daniel Andrews said.
To make sure students have the advanced skills to meet industry needs, the centre will be advised by a Scientific Advisory Group, including representatives from industry leaders, the CSIRO and the Therapeutic Goods Administration.
The centre – which will be the leading specialist mRNA training facility in the Asia Pacific – will train the future mRNA workforce, such as those from in Wyndham, to help put Victoria at the forefront of the region’s vaccine and medicine manufacturing.
Victoria is responsible for almost 60 per cent of Australia’s pharmaceutical exports – making it our highest-value advanced manufactured export.
